Clinical Trial Update: Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg [Phase 1]

View source ↗

Summary

This Phase 1 study evaluating Sorafenib with isolated limb infusion of melphalan for stage III melanoma of the arm or leg has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melphalan (Melphalan)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Duke University | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED